Medicare Enrolled
Dr. Gustavo Cardenas, MD
Cardiovascular Disease · Delray Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cardenas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cardenas? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cardenas
Dr. Gustavo Cardenas is a cardiovascular disease in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cardenas performed 10,202 Medicare services across 4,792 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cardenas received a total of $65,944 from 71 pharmaceutical and/or device companies across 887 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cardenas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 7% volume in FL$ $65,944 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,202
Medicare services
Top 7% in FL for cardiovascular disease
4,792
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~537 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 2,129 | $73 | $118 |
| Remote patient monitoring management, 20 min/month | 935 | $40 | $80 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 740 | $29 | $55 |
| Remote patient monitoring device, 30 days | 713 | $40 | $95 |
| Electrocardiogram (EKG), 12-lead | 693 | $12 | $27 |
| Hospital follow-up visit, high complexity | 684 | $99 | $164 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 674 | $21 | $45 |
| Echocardiogram, transthoracic | 455 | $156 | $321 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 447 | $33 | $66 |
| Initial hospital admission, high complexity | 298 | $144 | $320 |
| Injection, dipyridamole, per 10 mg | 289 | $3 | $48 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 274 | $90 | $177 |
| Office visit, established patient (30-39 min) | 256 | $103 | $170 |
| EKG interpretation and report | 197 | $7 | $9 |
| New patient office visit (45-59 min) | 190 | $136 | $260 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 136 | $357 | $736 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $50 | $110 |
| Remote pacemaker/defibrillator monitoring, 90 days | 111 | $18 | $40 |
| Ultrasound of both sides of head and neck blood flow | 98 | $154 | $310 |
| Emergency department visit, high complexity | 86 | $147 | $282 |
| Remote pacemaker monitoring, 90 days | 82 | $24 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test | 60 | $27 | $89 |
| Hospital follow-up visit, moderate complexity | 59 | $66 | $114 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 55 | $21 | $43 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 53 | $668 | $1,083 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 49 | $154 | $303 |
| Cardiac catheterization | 45 | $206 | $507 |
| Initial hospital admission, moderate complexity | 36 | $109 | $219 |
| Insertion of heart rhythm monitor under skin | 33 | $3,541 | $7,799 |
| Emergency department visit, moderate complexity | 28 | $102 | $194 |
| Coronary stent placement | 24 | $519 | $1,031 |
| Injection for imaging of aorta above heart valve with review by radiologist | 23 | $34 | $202 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $299 | $643 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 17 | $16 | $29 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 14 | $212 | $431 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $80 | $165 |
| Ultrasound of leg arteries or artery grafts | 13 | $197 | $394 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $86 | $172 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $14 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $2 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.5% high complexity
7.9% medium
84.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$65,944
Total received (2018-2024)
Avg $9,421/year across 7 years
Top 6% in FL for cardiovascular disease
71
Companies
887
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$44,807 (67.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,126 (32.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,016
2023$3,248
2022$2,968
2021$3,887
2020$2,578
2019$24,414
2018$25,834
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$46,474
Edwards Lifesciences Corporation
$2,848
Actelion Pharmaceuticals US, Inc.
$1,458
Janssen Pharmaceuticals, Inc
$1,264
Philips Electronics North America Corporation
$1,157
Penumbra, Inc.
$1,126
Amgen Inc.
$1,123
AstraZeneca Pharmaceuticals LP
$1,026
ABIOMED
$870
Novartis Pharmaceuticals Corporation
$752
Amarin Pharma Inc.
$542
Boehringer Ingelheim Pharmaceuticals, Inc.
$482
E.R. Squibb & Sons, L.L.C.
$464
Merck Sharp & Dohme LLC
$451
PFIZER INC.
$434
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$354
Bard Peripheral Vascular, Inc.
$306
HeartFlow, Inc.
$305
BIOTRONIK INC.
$298
SANOFI-AVENTIS U.S. LLC
$293
Kowa Pharmaceuticals America, Inc.
$226
Lundbeck LLC
$226
Boston Scientific Corporation
$206
Musculoskeletal Transplant Foundation Inc.
$181
CVRx, Inc.
$177
W. L. Gore & Associates, Inc.
$171
CARDIVA MEDICAL, INC.
$160
Medtronic Vascular, Inc.
$160
Biosense Webster, Inc.
$154
Kestra Medical Technology Services, Inc.
$153
Esperion Therapeutics, Inc.
$150
Gilead Sciences, Inc.
$133
Medtronic, Inc.
$122
Impulse Dynamics (USA) Inc.
$120
ATRICURE, INC.
$112
Bolton Medical Inc
$99
Chiesi USA, Inc.
$91
Merck Sharp & Dohme Corporation
$88
Kiniksa Pharmaceuticals, Ltd.
$83
Alnylam Pharmaceuticals Inc.
$77
ARBOR PHARMACEUTICALS, INC.
$77
Bayer HealthCare Pharmaceuticals Inc.
$68
Cardinal Health 200, LLC
$61
Becton, Dickinson and Company
$60
Lexicon Pharmaceuticals, Inc.
$59
Regeneron Healthcare Solutions, Inc.
$52
United Therapeutics Corporation
$51
Novo Nordisk Inc
$51
GE HEALTHCARE
$44
AGEPHA Pharma FZ LLC
$43
Aziyo Biologics, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$36
BOSTON SCIENTIFIC CORPORATION
$35
Braemar Manufacturing, LLC
$35
Kiniksa Pharmaceuticals International, plc
$32
Shockwave Medical, Inc
$31
Inari Medical, Inc.
$29
AtriCure, Inc.
$27
ACIST MEDICAL SYSTEMS, INC.
$22
Akcea Therapeutics, Inc.
$20
Venclose Inc.
$19
Astellas Pharma US Inc
$16
Biocompatibles, Inc.
$16
ShockWave Medical, Inc
$14
ZOLL Circulation Inc
$14
G Medical Diagnostic Services, Inc.
$14
ASAHI INTECC USA, INC.
$14
Tactile Systems Technology Inc
$13
CHIESI USA, INC.
$13
Acera Surgical, Inc.
$13
ARALEZ PHARMACEUTICALS US INC.
$13
Top 3 companies account for 77.0% of total payments
Associated products mentioned in payments ›
(6554) Periph Vasc Undiv · (7999) SRC Undivided · AMPLATZER AMULET · AMPLATZER Occluders · ASAHI PTCA Guide Wire Minamo · AVEIR · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · BELSOMRA · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CLEVIPREX · CONFIRM RX · CVI SYSTEMS · Cardiac Monitoring Suite · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · Cobalt · Confirm Rx · Connectivity and Remote care · Corlanor · ECM · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EPIC · EXELON PATCH · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · EnSite X · FARXIGA · FFRct · FLEXITOUCH · FLOWTRIEVER CATHETER · Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter · GORE VIABAHN VBX Balloon Expandable Endo · General - Therapies · HawkOne · IGT D Peripheral · INVOKANA · Impella · Indigo · Indigo System · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LIVALO · LODOCO · LifeVest · Livalo · MERLIN@HOME · MICRA · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · MynxGrip Vascular Closure Device · NA · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Omnilink Elite vascular stent system · Optimizer Smart System · Optis Coronary Imaging System · Ozempic · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Penumbra System · RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM · Repatha · Restrata Wound Matrix · Reveal LINQ · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY ABLATION SYSTEM · Smart Coil · Supera peripheral stent system · TEGSEDI · TYVASO · TherOx DS2 Console · Tryton Side Branch Stent · UPTRAVI · VARITHENA · VERQUVO · VIABAHN VBX Balloon Expandable Endoprosthesis · VYNDAMAX · VYNDAQEL · Vascepa · Vascular Closure Device · Vascular Lithotripsy · Venclose Maven Catheter · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · Xience cornary stent systems · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for cardiovascular disease in FL.
Equivalent to $646 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
226
Per 100K population
15.0
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cardenas is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (consulting-driven, top 6%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cardenas experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Cardenas performed 2,129 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cardenas receive payments from pharmaceutical companies?
Yes. Dr. Cardenas received a total of $65,944 from 71 companies across 887 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cardenas's costs compare to other cardiovascular diseases in Delray Beach?
Dr. Cardenas's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cardenas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Delray Beach
Browse cardiovascular diseases in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology